LifeSci Capital Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $30

Futu NewsDec 11 05:32 · Ratings

A Quick Look at Today's Ratings for Kura Oncology(KURA.US), With a Forecast Between $28 to $37

Futu NewsDec 10 21:00 · Ratings

Jonathan Chang Recommends 'Buy' on Kura Oncology Amid Promising Ziftomenib Advancements in AML Treatment

TipRanksDec 10 14:07

Analysts Are Bullish on Top Healthcare Stocks: Stoke Therapeutics (STOK), Kura Oncology (KURA)

TipRanksDec 10 03:20 · Ratings

Cantor Fitzgerald Reiterates Overweight on Kura Oncologyto Overweight

BenzingaDec 9 22:59

Kura Oncology Provided Clinical Data From KOMET-007 Phase 1 Dose-escalation Trial Of Ziftomenib In Combination With Standards Of Care For NPM1-mutant And KMT2A-rearranged Acute Myeloid Leukemia

BenzingaDec 9 20:07